Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus
Endothelial function is impaired in healthy subjects at risk of type 2 diabetes mellitus (DM). We investigated whether endothelial dysfunction can be normalized by statin therapy in this potentially predisposed population. Flow-mediated dilation (FMD) was measured in 56 first-degree relatives (FDRs)...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/2522/1/cardiovascular_theraputics..pdf |
| _version_ | 1825718692429692928 |
|---|---|
| author | Amudha, K. Choy, A.M. Mustafa, Mohd Rais Lang, C.C. |
| author_facet | Amudha, K. Choy, A.M. Mustafa, Mohd Rais Lang, C.C. |
| author_sort | Amudha, K. |
| collection | UM |
| description | Endothelial function is impaired in healthy subjects at risk of type 2 diabetes mellitus (DM). We investigated whether endothelial dysfunction can be normalized by statin therapy in this potentially predisposed population. Flow-mediated dilation (FMD) was measured in 56 first-degree relatives
(FDRs) (normotensive, normal glucose tolerance) and 20 age-, sex-, and BMI-matched controls with no family history of DM. Other measurements included insulin resistance index using the homeostasis model of insulin resistance (HOMAIR), plasma lipids, and markers of inflammation. The FDRs
were then randomized and treated with atorvastatin (80 mg) or placebo daily in a 4-week double-blind, placebo-controlled trial. The FDRs had significantly impaired FMD (4.4 ± 8.1% vs. 13.0 ± 4.2%; P < 0.001), higher HOMAIR (1.72 ± 1.45 vs. 1.25 ± 0.43; P = 0.002), and elevated levels of plasma markers of inflammation—highly sensitive C-reactive protein (hsCRP) (2.6 ± 3.8 mg/L vs. 0.7 ± 1.0 mg/L; P = 0.06), interleukin (IL)-6 (0.07 ± 0.13 ng/mL vs. 0.03 ± 0.01 ng/mL; P < 0.001), and soluble intercellular adhesion molecule (sICAM) (267.7 ± 30.7 ng/mL vs.
238.2 ± 20.4 ng/mL; P < 0.001). FMD improved in the atorvastatin-treated subjects when compared with the placebo-treated subjects (atorvastatin, from
3.7 ± 8.5% to 9.8 ± 7.3%; placebo, from 3.9 ± 5.6% to 4.7 ± 4.2%; P = 0.001). There were also reductions in the levels of IL-6 (0.08 ± 0.02 ng/mL vs. 0.04 ± 0.01 ng/mL; P < 0.001) and hsCRP (3.0 ± 3.9 mg/L vs. 1.0 ± 1.3 mg/L;
P = 0.006). Our study suggests that treatment with atorvastatin may improve endothelial function and decrease levels of inflammatory markers in FDRs of type 2 DM patients. |
| first_indexed | 2024-03-06T05:08:16Z |
| format | Article |
| id | um.eprints-2522 |
| institution | Universiti Malaya |
| language | English |
| last_indexed | 2024-03-06T05:08:16Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | um.eprints-25222019-12-18T06:24:23Z http://eprints.um.edu.my/2522/ Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus Amudha, K. Choy, A.M. Mustafa, Mohd Rais Lang, C.C. R Medicine (General) RM Therapeutics. Pharmacology Endothelial function is impaired in healthy subjects at risk of type 2 diabetes mellitus (DM). We investigated whether endothelial dysfunction can be normalized by statin therapy in this potentially predisposed population. Flow-mediated dilation (FMD) was measured in 56 first-degree relatives (FDRs) (normotensive, normal glucose tolerance) and 20 age-, sex-, and BMI-matched controls with no family history of DM. Other measurements included insulin resistance index using the homeostasis model of insulin resistance (HOMAIR), plasma lipids, and markers of inflammation. The FDRs were then randomized and treated with atorvastatin (80 mg) or placebo daily in a 4-week double-blind, placebo-controlled trial. The FDRs had significantly impaired FMD (4.4 ± 8.1% vs. 13.0 ± 4.2%; P < 0.001), higher HOMAIR (1.72 ± 1.45 vs. 1.25 ± 0.43; P = 0.002), and elevated levels of plasma markers of inflammation—highly sensitive C-reactive protein (hsCRP) (2.6 ± 3.8 mg/L vs. 0.7 ± 1.0 mg/L; P = 0.06), interleukin (IL)-6 (0.07 ± 0.13 ng/mL vs. 0.03 ± 0.01 ng/mL; P < 0.001), and soluble intercellular adhesion molecule (sICAM) (267.7 ± 30.7 ng/mL vs. 238.2 ± 20.4 ng/mL; P < 0.001). FMD improved in the atorvastatin-treated subjects when compared with the placebo-treated subjects (atorvastatin, from 3.7 ± 8.5% to 9.8 ± 7.3%; placebo, from 3.9 ± 5.6% to 4.7 ± 4.2%; P = 0.001). There were also reductions in the levels of IL-6 (0.08 ± 0.02 ng/mL vs. 0.04 ± 0.01 ng/mL; P < 0.001) and hsCRP (3.0 ± 3.9 mg/L vs. 1.0 ± 1.3 mg/L; P = 0.006). Our study suggests that treatment with atorvastatin may improve endothelial function and decrease levels of inflammatory markers in FDRs of type 2 DM patients. 2008 Article PeerReviewed application/pdf en http://eprints.um.edu.my/2522/1/cardiovascular_theraputics..pdf Amudha, K. and Choy, A.M. and Mustafa, Mohd Rais and Lang, C.C. (2008) Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus. Cardiovascular Theraputics, 26 (4). pp. 253-261. DOI https://doi.org/10.1111/j.1755-5922.2008.00064. <https://doi.org/10.1111/j.1755-5922.2008.00064.>. doi: 10.1111/j.1755-5922.2008.00064. |
| spellingShingle | R Medicine (General) RM Therapeutics. Pharmacology Amudha, K. Choy, A.M. Mustafa, Mohd Rais Lang, C.C. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title | Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title_full | Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title_fullStr | Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title_full_unstemmed | Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title_short | Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with Type 2 Diabetes Mellitus |
| title_sort | short term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus |
| topic | R Medicine (General) RM Therapeutics. Pharmacology |
| url | http://eprints.um.edu.my/2522/1/cardiovascular_theraputics..pdf |
| work_keys_str_mv | AT amudhak shorttermeffectofatorvastatinonendothelialfunctioninhealthyoffspringofparentswithtype2diabetesmellitus AT choyam shorttermeffectofatorvastatinonendothelialfunctioninhealthyoffspringofparentswithtype2diabetesmellitus AT mustafamohdrais shorttermeffectofatorvastatinonendothelialfunctioninhealthyoffspringofparentswithtype2diabetesmellitus AT langcc shorttermeffectofatorvastatinonendothelialfunctioninhealthyoffspringofparentswithtype2diabetesmellitus |